
Helaine I. Fingold
Articles
-
Aug 7, 2024 |
jdsupra.com | Helaine I. Fingold
While the Supreme Court decision in Loper Bright Enterprises v. Raimondo was making headlines, other courts were considering recent regulations of another agency—the Centers for Medicare and Medicaid Services (CMS)—that are material to Medicare Advantage.
-
Apr 1, 2024 |
jdsupra.com | Alexis Boaz |Helaine I. Fingold |Karen Mandelbaum
The Centers for Medicare & Medicaid Services (CMS) recently published the CMS Advancing Interoperability and Improving Prior Authorization Processes Final Rule (“PA Final Rule”) in the Federal Register. Effective April 8, 2024, with rolling implementation dates of certain provisions, the PA Final Rule imposes requirements on payers that will have wide-reaching impacts across other health care stakeholders—particularly providers and patients.
-
Aug 14, 2023 |
jdsupra.com | Alexis Boaz |Helaine I. Fingold
On August 3, 2023, the U.S. Department of Health & Human Services (“HHS”), the Department of Labor, and the Department of Treasury (collectively, the “Departments”) temporarily suspended the federal Independent Dispute Resolution (“IDR”) process immediately following the issuance of a decision by the U.S. District Court for the Eastern District of Texas (the “Court”) that vacated certain regulations and guidance the Departments issued to implement the No Surprises Act (“NSA”).
-
Aug 14, 2023 |
lexblog.com | Alexis Boaz |Helaine I. Fingold
On August 3, 2023, the U.S. Department of Health & Human Services (“HHS”), the Department of Labor, and the Department of Treasury (collectively, the “Departments”) temporarily suspended the federal Independent Dispute Resolution (“IDR”) process immediately following the issuance of a decision by the U.S. District Court for the Eastern District of Texas (the “Court”) that vacated certain regulations and guidance the Departments issued to implement the No Surprises Act (“NSA”).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →